Clinical Trials – New Treatments | 0021 | ESPEYB21 | Yearbook of Paediatric Endocrinology 2024 | ESPE Yearbook of Paediatric Endocrinology

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 21 | ESPEYB21

Yearbook of Paediatric Endocrinology 2024

10. Type 1 Diabetes

Clinical Trials – New Treatments

Previous section
M. Loredana Marcovecchio, Marie-Anne Burckhardt

Table of contents

Next section
Important for Clinical Practice

ey0021.10-1 | Clinical Trials – New Treatments

10.1. Baricitinib and beta-cell function in patients with new-onset type 1 diabetes

ey0021.10-2 | Clinical Trials – New Treatments

10.2. Teplizumab and beta-cell function in newly diagnosed type 1 diabetes

ey0021.10-3 | Clinical Trials – New Treatments

10.3. Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more